Reham Soliman
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
Papers in
- Hepatology 40
- Hepatitis C virus research 35
- Liver Disease and Transplantation 9
- Liver Diseases and Immunity 4
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Epidemiology 38
- Liver Disease Diagnosis and Treatment 32
- Hepatitis B Virus Studies 18
- Co-authors
- Gamal Shiha (44 shared papers)Nabiel Mikhail (17 shared papers)Mohamed Elbasiony (10 shared papers)Philippa Easterbrook (6 shared papers)Wahid Doss (3 shared papers)Gamal Esmat (5 shared papers)Mohamed Hassany (5 shared papers)Ammal M. Metwally (3 shared papers)
- Journals
- Journal of Hepatology (7 papers)Journal of Viral Hepatitis (4 papers)Hepatology International (3 papers)Liver International (2 papers)Scientific Reports (2 papers)
- Partner nations
- EgyptUnited StatesSwitzerland
In The Last Decade
Reham Soliman
42 papers receiving 641 citations
Peers
Comparison fields: 5 of 71
- Hepatology 533
- Epidemiology 517
- Infectious Diseases 71
- Applied Microbiology and Biotechnology 5
- Molecular Medicine 11
Countries citing papers authored by Reham Soliman
This map shows the geographic impact of Reham Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reham Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reham Soliman more than expected).
Fields of papers citing papers by Reham Soliman
This network shows the impact of papers produced by Reham Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reham Soliman. The network helps show where Reham Soliman may publish in the future.
Co-authors
The 25 scholars most cited alongside Reham Soliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 114 | |
| 2 | 2016 | 53 | |
| 3 | 2018 | 46 | |
| 4 | 2020 | 41 | |
| 5 | 2018 | 34 | |
| 6 | 2019 | 32 | |
| 7 | 2020 | 27 | |
| 8 | 2020 | 26 | |
| 9 | 2019 | 25 | |
| 10 | 2018 | 25 | |
| 11 | 2020 | 21 | |
| 12 | 2021 | 19 | |
| 13 | 2017 | 17 | |
| 14 | 2020 | 16 | |
| 15 | 2022 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2020 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2019 | 11 | |
| 20 | 2015 | 10 |
About Reham Soliman
Reham Soliman is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Surgery and Rheumatology, having authored 49 papers that have together received 651 indexed citations. Recurring topics across this work include Hepatitis C virus research (35 papers), Liver Disease Diagnosis and Treatment (32 papers), Hepatitis B Virus Studies (18 papers), Liver Disease and Transplantation (9 papers), Liver Diseases and Immunity (4 papers), COVID-19 Clinical Research Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Hepatology (533 citations), Epidemiology (517 citations), Infectious Diseases (71 citations), Applied Microbiology and Biotechnology (5 citations) and Molecular Medicine (11 citations). Reham Soliman has collaborated with scholars based in Egypt, United States and Switzerland. Frequent co-authors include Gamal Shiha, Nabiel Mikhail, Mohamed Elbasiony, Philippa Easterbrook, Wahid Doss, Gamal Esmat, Mohamed Hassany, Ammal M. Metwally, Rabab Fouad and Benedetta Massetto. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Hepatology International, Liver International and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.